Clinical Trials Directory

Trials / Completed

CompletedNCT01313182

Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin

Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,874 (actual)
Sponsor
Solventum US LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We hypothesize the application of mupirocin or povidone-iodine to the nares is equally effective in short term Staphylococcus aureus(SA)suppression. Our overall study objective is to measure the rate of deep and superficial Surgical Site Infections (SSIs) after primary hip, knee, shoulder and elbow arthroplasty surgery and primary spinal fusion surgery requiring implantation of prosthetic material, when the patient receives either nasal mupirocin or nasal povidone-iodine prior to surgery. Secondary study objectives include: 1. Measure hospital length of stay and re-admission rates in the mupirocin and povidone-iodine groups. 2. Measure adverse events related to mupirocin and povidone-iodine. 3. Measure rate of SA resistance to mupirocin.

Detailed description

We hypothesize the application of mupirocin or povidone-iodine to the nares is equally effective in short term Staphylococcus aureus(SA)suppression. Our overall study objective is to measure the rate of deep and superficial Surgical Site Infections (SSIs) after primary hip, knee, shoulder and elbow arthroplasty surgery and primary spinal fusion surgery requiring implantation of prosthetic material, when the patient receives either nasal mupirocin or nasal povidone-iodine prior to surgery.

Conditions

Interventions

TypeNameDescription
DRUGmupirocin calcium ointment, 2%Approximately one-half of the ointment from the single-use tube should be applied into 1 nostril and the other half into the other nostril twice daily (morning and evening) for 5 days. After application, the nostrils should be closed by pressing together and releasing the sides of the nose repetitively for approximately 1 minute. This will spread the ointment throughout the nares.
DRUG3M Skin and Nasal AntisepticThe solution is applied to for 30 seconds to each nostril twice for a total of 2 minutes. The solution is applied by rotating the applicator around the circumference of the nostril for 15 seconds and then rotating the applicator in the anterior nares for 15 seconds.

Timeline

Start date
2011-03-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2011-03-11
Last updated
2024-12-02
Results posted
2014-05-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01313182. Inclusion in this directory is not an endorsement.